Drug Shortage Report for ALPHAGAN
Report ID | 97091 |
Drug Identification Number | 02236876 |
Brand name | ALPHAGAN |
Common or Proper name | brimonidine tartrate |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.2% |
Dosage form(s) | LIQUID |
Route of administration | OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-10-30 |
Actual start date | 2019-11-05 |
Estimated end date | 2019-12-25 |
Actual end date | 2019-12-24 |
Shortage status | Resolved |
Updated date | 2019-12-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-12-25 | English | Compare |
v8 | 2019-12-24 | French | Compare |
v7 | 2019-12-24 | English | Compare |
v6 | 2019-12-05 | English | Compare |
v5 | 2019-11-07 | French | Compare |
v4 | 2019-11-07 | English | Compare |
v3 | 2019-10-31 | English | Compare |
v2 | 2019-10-24 | French | Compare |
v1 | 2019-10-24 | English | Compare |
Showing 1 to 9 of 9